-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Monday's Pre-Market Session
Share
Listen to the news

Gainers

  • Onconetix (NASDAQ:ONCO) shares rose 39.8% to $0.82 during Monday's pre-market session.
  • Sagimet Biosciences (NASDAQ:SGMT) shares rose 28.32% to $7.52. The market value of their outstanding shares is at $190.9 million.
  • Oruka Therapeutics (NASDAQ:ORKA) shares increased by 23.13% to $85.0. The company's market cap stands at $3.4 billion.
  • Veradermics (NYSE:MANE) stock rose 20.84% to $81.98. The market value of their outstanding shares is at $2.3 billion.
  • Organon (NYSE:OGN) stock moved upwards by 16.87% to $13.16. The company's market cap stands at $2.9 billion.
  • Rallybio (NASDAQ:RLYB) stock rose 15.99% to $10.01. The company's market cap stands at $45.6 million.

Losers

  • Compass Therapeutics (NASDAQ:CMPX) stock decreased by 24.5% to $3.8 during Monday's pre-market session. The market value of their outstanding shares is at $692.0 million.
  • Q32 Bio (NASDAQ:QTTB) shares declined by 17.05% to $5.16. The market value of their outstanding shares is at $90.9 million.
  • Aditxt (NASDAQ:ADTX) shares fell 12.81% to $0.25.
  • Medicus Pharma (NASDAQ:MDCX) stock decreased by 12.74% to $0.27. The company's market cap stands at $9.3 million.
  • Scinai Immunotherapeutics (NASDAQ:SCNI) stock decreased by 8.28% to $0.68. The market value of their outstanding shares is at $2.6 million.
  • iTonic Holdings (NASDAQ:ITOC) stock declined by 8.19% to $0.34. The market value of their outstanding shares is at $6.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending